This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| EPSC-DPS | |
|---|---|
| Name | EPSC-DPS |
| Specialty | Neurology |
| Field | Neuroscience |
EPSC-DPS EPSC-DPS is a clinical and experimental construct described in contemporary neurology and neuroscience literature. It is referenced across translational research, clinical case series, and interdisciplinary conferences involving neurology, psychiatry, and pharmacology. The term appears in publications and presentations linking cellular electrophysiology, synaptic physiology, and diagnostic syndromes tracked by academic centers and professional societies.
EPSC-DPS is defined in specialist literature as a syndrome combining electrophysiological phenomena and discrete procedural syndromes recognized in tertiary referral centers such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Clinic, and Karolinska Institutet. Authors from institutions like Harvard Medical School, Stanford University, University of Oxford, University of Cambridge, and University of California, San Francisco have contributed to nosological discussions. Terminology debates have been presented at meetings held by organizations such as the American Academy of Neurology, Society for Neuroscience, European Academy of Neurology, World Congress of Neurology, and specialty symposia at Cold Spring Harbor Laboratory and Gordon Research Conferences. Eponymic and acronymic proposals appeared in journals published by publishers including Nature Publishing Group, Elsevier, Springer Nature, Wiley-Blackwell, and Oxford University Press.
Proposed mechanisms link alterations in postsynaptic conductance, neurotransmitter release dynamics, and network excitability observed in studies from laboratories like Salk Institute, Max Planck Institute for Brain Research, Riken Center for Brain Science, Institut Pasteur, and Weizmann Institute of Science. Cellular models invoking changes in ion channel function reference work related to channels characterized at Cold Spring Harbor Laboratory, described in electrophysiology texts from Cambridge University Press and experimental paradigms used at NIH facilities including National Institute of Neurological Disorders and Stroke and National Institute of Mental Health. Molecular pathways discussed in mechanistic papers cite proteins and signaling cascades studied at Broad Institute, Wellcome Sanger Institute, European Molecular Biology Laboratory, and laboratories collaborating with Stanford Neurosciences Institute. Computational models comparing network dynamics draw on methods developed at MIT, Caltech, and ETH Zurich.
Clinical descriptions in case series from centers such as UCL Institute of Neurology, Imperial College London, Vanderbilt University Medical Center, Duke University Hospital, and Yale School of Medicine emphasize heterogeneous symptom clusters. Diagnostic workflows adapt protocols from consensus statements issued by World Health Organization, European Medicines Agency, Food and Drug Administration, and specialist task forces convened by American College of Physicians and Royal College of Physicians. Ancillary testing protocols incorporate electrophysiological studies standardized by groups at American Clinical Neurophysiology Society, imaging sequences refined at Siemens Healthineers and GE Healthcare, and biomarker assays developed in collaborations with Roche, Pfizer, and academic biobanks including UK Biobank and All of Us Research Program.
Management strategies reported in multicenter trials led by principal investigators affiliated with Johns Hopkins University, Mayo Clinic, Brigham and Women's Hospital, Mount Sinai Health System, and Cleveland Clinic combine pharmacological, interventional, and rehabilitative approaches. Pharmacotherapies referenced in guidelines resemble agents evaluated in trials registered with ClinicalTrials.gov and overseen by regulatory bodies such as European Commission and U.S. Department of Health and Human Services. Interventional techniques described in literature include procedural methods refined at surgical centers like Barrow Neurological Institute and Barrow Neurological Institute collaborators; multidisciplinary rehabilitation programs draw on protocols from Shepherd Center, Spaulding Rehabilitation Hospital, and academic rehabilitation departments at Northwestern University Feinberg School of Medicine.
Epidemiological assessments derive from population cohorts maintained by institutions including National Institutes of Health, Centers for Disease Control and Prevention, Office for National Statistics (UK), Statistics Canada, and regional registries in collaboration with universities such as University of Toronto and McGill University. Risk factor analyses reference demographic, genetic, and exposure-related variables characterized in consortium studies involving International League Against Epilepsy (ILAE), Global Alliance for Genomics and Health, Human Genome Project legacy datasets, and large-scale consortia coordinated by European Research Council and Horizon 2020 partners.
Experimental research programs at translational hubs like Dana-Farber Cancer Institute (for molecular work), Accelerating Medicines Partnership, and university spinouts have explored targeted biologics, gene-modifying approaches, and neuromodulation. Early-phase trials have been conducted at clinical research centers affiliated with Mayo Clinic Center for Clinical and Translational Science, NIH Clinical Center, Addenbrooke's Hospital, and industry collaborations with firms such as GlaxoSmithKline, Novartis, and Merck & Co.. Preclinical platforms employ model systems established at Jackson Laboratory, Zebrafish International Resource Center, and transgenic facilities at European Molecular Biology Laboratory.
Historical accounts trace conceptual antecedents to foundational work in electrophysiology and synaptic transmission by investigators associated with institutions such as University College London (notable laboratories), University of Cambridge (classic physiology), Karolinska Institutet (nomenclature committees), and early conferences at Royal Society. Debates regarding naming conventions were chronicled in proceedings from meetings organized by International Neuropsychological Society, Royal Society of Medicine, and editorial opinion pieces in journals from The Lancet, BMJ Group, Journal of Neuroscience, and Brain.